Short Interest in Silo Pharma, Inc. (NASDAQ:SILO) Increases By 38.7%

Silo Pharma, Inc. (NASDAQ:SILO) was the recipient of a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 181,200 shares, an increase of 38.7% from the February 28th total of 130,600 shares. Based on an average daily volume of 2,900,000 shares, the short-interest ratio is currently 0.1 days. Currently, 4.2% of the shares of the company are short sold.

Silo Pharma Price Performance

Shares of SILO opened at $1.25 on Monday. The company’s 50-day moving average is $1.50 and its 200-day moving average is $1.24. Silo Pharma has a fifty-two week low of $0.77 and a fifty-two week high of $4.50.

Silo Pharma (NASDAQ:SILO) last released its quarterly earnings results on Friday, March 28th. The company reported ($0.41) earnings per share for the quarter. Silo Pharma had a negative net margin of 5,255.05% and a negative return on equity of 61.38%. The company had revenue of $0.02 million during the quarter.

Silo Pharma Company Profile

Silo Pharma Inc operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems.